Stockscreener 앱 받기
11.34
5.19%
0.56
전일 마감가:
$10.78
열려 있는:
$10.65
하루 거래량:
36,910
Relative Volume:
0.11
시가총액:
$27.59M
수익:
-
순이익/손실:
$-11.62M
주가수익비율:
-2.025
EPS:
-5.6
순현금흐름:
$-6.91M
1주 성능:
-12.43%
1개월 성능:
+68.00%
6개월 성능:
+176.18%
1년 성능:
+5.10%
1일 변동 폭
$10.03
$11.75
1주일 범위
$8.65
$12.76
52주 변동 폭
$2.31
$13.70
Coeptis Therapeutics Holdings Inc Stock (COEP) Company Profile
명칭
Coeptis Therapeutics Holdings Inc
전화
724-934-6467
주소
105 BRADFORD ROAD, SUITE 420, WEXFORD
COEP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
COEP
COEPTIS THERAPEUTICS INC
|
6.99 | 2.70M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.1978 | 409.20M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
GOODO
Gladstone Commercial Corporation
|
20.70 | 372.90M | 0 | 0 | 0 | 0.00 |
|
MOBBW
Mobilicom Limited Warrants
|
0.4356 | 278.60M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
2.26 | 96.03M | 0 | 0 | 0 | 0.00 |
|
JUNE
Dhandho Junoon Etf
|
4.00 | 52.42M | 0 | 0 | 0 | 0.00 |
Coeptis Therapeutics Holdings Inc 주식(COEP)의 최신 뉴스
10 AI News Updates Making Waves on Wall Street - Insider Monkey
Strategic $10M Funding Positions Coeptis for AI-Powered Biotech Revolution - StockTitan
Coeptis Therapeutics Holdings, Inc. (COEP): Pioneering AI-Powered Marketing for Healthcare Innovation - Insider Monkey
10 AI News and Ratings Investors Should Take a Look At - Insider Monkey
Local biopharmaceutical company rebrands, embracing AI and blockchain technologiesPittsburgh Business Times - The Business Journals
Coeptis Therapeutics shifts focus with rebrand and AI tech - MSN
Coeptis Therapeutics Holdings Becomes COEPTIS: Embracing a Future of Technology and Innovation - Citizentribune
Coeptis Therapeutics shifts focus with rebrand and AI tech By Investing.com - Investing.com Australia
Pharma Company Makes Bold AI Pivot: Inside Coeptis's Tech Transformation - StockTitan
Coeptis Therapeutics Holdings, Inc. announced that it has received $1.1 million in funding from Yorkville Advisors Global LP - Marketscreener.com
Coeptis Therapeutics secures $1.1 million convertible note By Investing.com - Investing.com Australia
Coeptis Therapeutics secures $1.1 million convertible note - Investing.com India
Coeptis Therapeutics Holdings expands technological initiatives - Pennsylvania Business Report
Coeptis Therapeutics Leverages Artificial Intelligence and Blockchain for Next-Generation Innovation - Marketscreener.com
Coeptis Boosts AI Capabilities, Explores Blockchain - Contract Pharma
Coeptis Therapeutics Expands Into AI and Blockchain Tech, Strengthens Digital Innovation Push - StockTitan
Coeptis Therapeutics Regains Nasdaq Compliance, Secures Exchange Listing Status - StockTitan
Coeptis Therapeutics (Nasdaq: COEP) Emerges as a Biopharma Innovator Leveraging AI-Driven Marketing - Barchart
Midday Market Movers: Biggest Stock Declines of the Day – Market - HPBL
Coeptis announces $1.7 million from new AI marketing deals - Investing.com
Coeptis Therapeutics Announces First Customer Adoptions of its NexGenAI Marketing Platform - PR Newswire
Eloxx Pharmaceuticals (NASDAQ:ELOX) & Coeptis Therapeutics (NASDAQ:COEP) Financial Comparison - Defense World
Coeptis Therapeutics Holdings Inc (NASDAQ: COEP): Getting A Free Pass? - Stocks Register
Stock market today: Heartcore Enterprises -20.07%, Caravelle International -16.63% among biggest losers in early trading - Business Upturn
Pre-market Movers: ONCO, COEP, NUVB, SPRC... - RTTNews
Coeptis Therapeutics (COEP) Stock Gains Pre-Hour Traction - Stocks Telegraph
Coeptis Therapeutics Expands License Agreement with University of Pittsburgh to Include SNAP-CAR NK Cell Technology - Marketscreener.com
Stock Market Drama! Tech Slumps While Surprising Gains Emerge! - Jomfruland.net
Coeptis Therapeutics Announces Phase 1 Data on DVX201 for COVID-19 Treatment Has Been Accepted for Publication in Molecular Therapy Methods and Clinical Development - Marketscreener.com
Coeptis Therapeutics Holdings, Inc. entered into a letter of intent to acquire Allogeneic Immuno-Oncology NK Platform in Phase 1 Clinical Trials from Deverra Therapeutics, Inc. - Marketscreener.com
Coeptis Therapeutics Holdings, Inc. Adds Autoimmune Indications to Exclusive License Agreement with University of Pittsburgh for SNAP-CAR T and SNAP-CAR NK - Marketscreener.com
Coeptis Therapeutics Holdings, Inc. signed a binding Letter of Intent to acquire NexGenAI Affiliates Network from NexGenAI Solutions Group, Inc. - Marketscreener.com
PHLX Swiss Franc (XDS) QuotePress Release - The Globe and Mail
S&P 500 Growth (IGX) QuotePress Release - The Globe and Mail
Nasdaq Biotechnology Index (NBI) QuotePress Release - The Globe and Mail
S&P 500 Health Care [Sector] (SRHC) QuotePress Release - The Globe and Mail
KBW Bank Index (BKX) QuotePress Release - The Globe and Mail
KBW Capital Markets Index (KSX) QuotePress Release - The Globe and Mail
KBW Insurance Index (KIX) QuotePress Release - The Globe and Mail
S&P 500 Consumer Discretionary [Sector] (SRCD) QuotePress Release - The Globe and Mail
KBW Property & Casualty Index (KPX) QuotePress Release - The Globe and Mail
Trading Halt Occurred During This Micro Cap's EOY Surge - MSN
Stock market news: Coeptis Therapeutics Holdings -96.03%, OptiNose -93.07% among biggest losers during mid day trading - Business Upturn
Stock market news: Coeptis Therapeutics Holdings declined by 96.03% whereas Baird Medical Investment Holdings +496.89% during mid day trading - Business Upturn
Stock market today: Coeptis Therapeutics Holdings -95.79%, OptiNose -93.64% among biggest losers in early trading - Business Upturn
Stock market today: Coeptis Therapeutics Holdings plunged by 95.98% whereas Baird Medical Investment Holdings gained over 201.90% in early trading - Business Upturn
TSX North American Pref Stock Index (STNU) QuotePress Release - The Globe and Mail
Coeptis Therapeutics announces reverse stock split - MSN
Coeptis Therapeutics announces reverse stock split plan to remain on the NasdaqPittsburgh Business Times - The Business Journals
Why Is Coeptis Therapeutics Stock Falling On Friday? - Benzinga
Coeptis Therapeutics Announced an Acquisition and a New Divison Launch - Martechcube
Coeptis Therapeutics Holdings Inc (COEP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.09%
자본화:
|
볼륨(24시간):